FI981956A7 - 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina - Google Patents

2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina Download PDF

Info

Publication number
FI981956A7
FI981956A7 FI981956A FI981956A FI981956A7 FI 981956 A7 FI981956 A7 FI 981956A7 FI 981956 A FI981956 A FI 981956A FI 981956 A FI981956 A FI 981956A FI 981956 A7 FI981956 A7 FI 981956A7
Authority
FI
Finland
Prior art keywords
hydroxypiperidino
alkanol derivatives
anemic agents
anemic
agents
Prior art date
Application number
FI981956A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI981956A0 (fi
FI981956L (fi
Inventor
Jr Willard Mckowan Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI981956A0 publication Critical patent/FI981956A0/fi
Publication of FI981956L publication Critical patent/FI981956L/fi
Publication of FI981956A7 publication Critical patent/FI981956A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI981956A 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina FI981956A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (3)

Publication Number Publication Date
FI981956A0 FI981956A0 (fi) 1998-09-11
FI981956L FI981956L (fi) 1998-09-11
FI981956A7 true FI981956A7 (fi) 1998-09-11

Family

ID=24940103

Family Applications (2)

Application Number Title Priority Date Filing Date
FI981956A FI981956A7 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina
FI940192A FI940192A0 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI940192A FI940192A0 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina

Country Status (22)

Country Link
EP (1) EP0594729A1 (enrdf_load_stackoverflow)
JP (1) JP2571904B2 (enrdf_load_stackoverflow)
KR (1) KR0165003B1 (enrdf_load_stackoverflow)
CN (1) CN1043759C (enrdf_load_stackoverflow)
AU (1) AU655840B2 (enrdf_load_stackoverflow)
BR (1) BR9206272A (enrdf_load_stackoverflow)
CA (1) CA2113568A1 (enrdf_load_stackoverflow)
CZ (1) CZ284133B6 (enrdf_load_stackoverflow)
EG (1) EG20048A (enrdf_load_stackoverflow)
FI (2) FI981956A7 (enrdf_load_stackoverflow)
HU (1) HUT70528A (enrdf_load_stackoverflow)
IE (1) IE922311A1 (enrdf_load_stackoverflow)
IL (1) IL102473A (enrdf_load_stackoverflow)
MX (1) MX9204190A (enrdf_load_stackoverflow)
NO (1) NO180445C (enrdf_load_stackoverflow)
NZ (1) NZ243580A (enrdf_load_stackoverflow)
PL (1) PL169884B1 (enrdf_load_stackoverflow)
PT (1) PT100689B (enrdf_load_stackoverflow)
RU (1) RU2065859C1 (enrdf_load_stackoverflow)
TW (1) TW201732B (enrdf_load_stackoverflow)
WO (1) WO1993002052A1 (enrdf_load_stackoverflow)
ZA (1) ZA925306B (enrdf_load_stackoverflow)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
CZ280669B6 (cs) * 1992-10-30 1996-03-13 Pfizer Inc. Deriváty 3,4-dihydro-2(1H)-chinolonu a farmaceutický prostředek na jejich bázi
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
WO2000061558A1 (fr) * 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. Remedes pour douleurs neurogenes
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
DK1379520T3 (da) 2001-02-23 2006-08-21 Merck & Co Inc N-substituerede ikke-aryl-heterocykliske NMDA/NR2B-antagonister
JP2005511478A (ja) 2001-04-03 2005-04-28 メルク　エンド　カムパニー　インコーポレーテッド Ｎ−置換非アリール複素環アミジル系ｎｍｄａ／ｎｒ２ｂ拮抗薬
WO2004048326A1 (ja) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
CA2541162A1 (en) * 2003-10-08 2005-04-21 Pfizer Inc. Fused lactam compounds
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途
IL299308A (en) * 2020-06-23 2023-02-01 Biohaven Therapeutics Ltd Cutaneous formulations of (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
ES2098248T3 (es) * 1989-05-17 1997-05-01 Pfizer Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos.
HU221193B1 (en) * 1990-05-10 2002-08-28 Pfizer Neuroprotective indole, qinoline and benzoxazolone derivatives, pharmaceutical compositions comprising such compounds and process for producing them

Also Published As

Publication number Publication date
FI940192A7 (fi) 1994-01-14
NO940144L (no) 1994-01-14
NZ243580A (en) 1994-10-26
RU2065859C1 (ru) 1996-08-27
PT100689B (pt) 1999-06-30
BR9206272A (pt) 1995-04-11
EG20048A (en) 1997-03-27
CN1043759C (zh) 1999-06-23
PT100689A (pt) 1993-10-29
FI981956A0 (fi) 1998-09-11
MX9204190A (es) 1993-01-01
ZA925306B (en) 1994-01-17
TW201732B (enrdf_load_stackoverflow) 1993-03-11
NO180445B (no) 1997-01-13
IE922311A1 (en) 1993-01-27
AU2322592A (en) 1993-02-23
WO1993002052A1 (en) 1993-02-04
AU655840B2 (en) 1995-01-12
HUT70528A (en) 1995-10-30
KR0165003B1 (en) 1999-01-15
EP0594729A1 (en) 1994-05-04
PL169884B1 (pl) 1996-09-30
FI940192L (fi) 1994-01-14
NO180445C (no) 1997-04-23
CZ284133B6 (cs) 1998-08-12
CA2113568A1 (en) 1993-02-04
CN1068566A (zh) 1993-02-03
NO940144D0 (no) 1994-01-14
JPH06504293A (ja) 1994-05-19
FI981956L (fi) 1998-09-11
IL102473A (en) 1997-07-13
JP2571904B2 (ja) 1997-01-16
FI940192A0 (fi) 1994-01-14
IL102473A0 (en) 1993-01-14
HU9400136D0 (en) 1994-05-30
CZ400892A3 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
FI981956A7 (fi) 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina
DE69226449D1 (de) 2-(2,6-difluorphenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-axazoline
FI934194A7 (fi) Varjoaineita
FI920840L (fi) Boggie foer raelsfordon
FI925295L (fi) Baenksystem foer kompositioner avsedda foer jordbruk
DE69304132D1 (de) Vorspinnmaschine
DK0543018T3 (da) Antidiabetikum
FI915026A7 (fi) 2-(substituoitu pyrrolidinyylitio)karbapeneemijohdannaisia
DE69303351D1 (de) Garnspulmaschine
DE69208949D1 (de) Kopiermaschine
FI913654A7 (fi) 2-(9-fluorenonyyli)-karbapeneemi
FI913655A7 (fi) 2-(9-fluorenonyyli)-karbapeneemi bakteerinvastaiset yhdisteet
FI931015A0 (fi) 2-(2-substituerade pyrrolidinyltio)karbapenemderivat
MX24301A (es) Agentes antipsicoticos espirociclicos
NO914640D0 (no) 2-(substituert pyrrolidinyltio) karbapenemderivater
SE9103275D0 (sv) Maskin
SE9101457D0 (sv) Maskin
SE9101074D0 (sv) Maskin
SE9101664D0 (sv) Maskin
SE9100849D0 (sv) Maskin
SE9103473D0 (sv) Maskin
SE9100178D0 (sv) Maskin
SE9102284D0 (sv) Maskin
ITMI911735A0 (it) Fresatrice-alesatrice
ITTO920723A1 (it) Macchina spietratrice